Evolution of hemostatic agents in surgical practice

Chandru P Sundaram, Alison C Keenan, Chandru P Sundaram, Alison C Keenan

Abstract

Objective: Topical hemostatic agents are used in a wide variety of surgical settings, and the evolution of this class of surgical tools is an interesting topic. We reviewed and outlined the historical progress of topical hemostats into present day surgery and urology, and highlight opportunities for future research.

Materials and methods: A MEDLINE search of all available literature concerning several classes of topical hemostatic agents was performed. Fibrins sealants, Gelatin sponge hemostatics, cyanoacrylate adhesives, oxidized regenerated cellulose, and microfibrillar collagen were included. References were chosen from a broad range of surgical literature.

Results: Topical hemostatic agents have historically taken advantage of a wide variety of mechanisms for hemostasis. Fibrin sealants have a rich history and large potential for further applications. Gelatin sponge hemostatics have been widely used since their introduction, but have changed little. Cyanoacrylate adhesives have a unique mechanism and opportunity for novel applications of existing products. Oxidized cellulose was original in the use of plant-based components. Microfibrillar collagen hemostats have evolved to a wide variety of formats.

Conclusions: A review of the evolution of topical hemostatic agents highlights opportunities for potential novel research. Fibrin sealants may have the most opportunity for advancement, and understanding the history of these products is useful. With the drive in urology for minimally invasive surgical techniques, adaptation of topical hemostatic agents to this surgical approach would be valuable and offers an opportunity for novel contributions.

Keywords: Fibrin sealant; gelfoam; hemostatic agents; microfibrillar collagen; oxidized regenerated cellulose.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Boucher BA, Traub O. Achieving hemostasis in the surgical field. Pharmacotherapy. 2009;29:2S–7S.
    1. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65:748–54.
    1. Rubin E, Gorstein F, Rubin R, Schwarting R, Strayer D. Baltimore: Lippincott: Williams and Wilkins; 2005. Rubin’s Pathology Clinicopathologic Foundations of Medicine.
    1. Franchini M, Lippi G. Factor V Leiden and hemophilia. Thromb Res. 2010;125:119–23.
    1. Bergel S. Uber die wirkung des fibrins. Dtsch Med Wochenschr. 1909;35:663–5.
    1. Spotnitz WD. Fibrin sealant: past, present, and future: a brief review. World J Surg. 2010;34:632–4.
    1. Jackson MR. Fibrin sealants in surgical practice: An overview. Am J Surg. 2001;182:1S–7S.
    1. Young J, Medawar P. Fibrin suture of peripheral nerves. Lancet. 1940;275:126–32.
    1. Cronkite E, Lozner E, Deaver J. Use of thrombin and fibrinogen in skin grafting. JAMA. 1944;124:976–8.
    1. Muntean W, Zenz W, Edlinger G, Beitzke A. Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin. Thromb Haemost. 1997;77:1223.
    1. Muntean W, Zenz W, Finding K, Zobel G, Beitzke A. Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two-year-old child. Acta Paediatr. 1994;83:84–7.
    1. Matras H. The use of fibrin sealant in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1982;40:617–22.
    1. Albala DM. Fibrin sealants in clinical practice. Cardiovasc Surg. 2003;11:5–11.
    1. Schexneider KI. Fibrin sealants in surgical or traumatic hemorrhage. Curr Opin Hematol. 2004;11:323–6.
    1. Mueller TJ, Dajusta DG, Cha DY, Kim IY, Ankem MK. Ureteral fibrin sealant injection of the distal ureter during laparoscopic nephroureterectomy-a novel and simple modification of the pluck technique. Urology. 2010;75:187–92.
    1. Zhang G, Zhao H, Sun ZY. A modified technique of renal artery anastomosis in rat kidney transplantation. Eur Surg Res. 2009;44:37–42.
    1. Gopal SC, Gangopadhyay AN, Mohan TV, Upadhyaya VD, Pandey A, Upadhyaya A, et al. Use of fibrin glue in preventing urethrocutaneous fistula after hypospadias repair. J Pediatr Surg. 2008;43:1869–72.
    1. Ambriz-González G, Velázquez-Ramírez GA, García-González JL, de León-Gómez JM, Muciño-Hernández MI, González-Ojeda A, et al. Use of fibrin sealant in hypospadias surgical repair reduces the frequency of postoperative complications. Urol Int. 2007;78:37–41.
    1. Choe CH, L’Esperance JO, Auge BK. The use of adjunctive hemostatic agents for tubeless percutaneous nephrolithotomy. J Endourol. 2009;23:1733–8.
    1. Safan A, Shaker H, Abdelaal A, Mourad MS, Albaz M. Fibrin glue versus martius flap interpositioning in the repair of complicated obstetric vesicovaginal fistula. A prospective multi-institution randomized trial. Neurourol Urodyn. 2009;28:438–41.
    1. Soon AS, Stabenfeldt SE, Brown WE, Barker TH. Engineering fibrin matrices: The engagement of polymerization pockets through fibrin knob technology for the delivery and retention of therapeutic proteins. Biomaterials. 2009 Nov 13.
    1. Pfizer GELFOAM package insert. Available from: [last cited on 2009]
    1. Singh P, Mandhani A. Use of absorbable gelatin sponge as an adjunct to “totally tubeless percutaneous nephrolithotomy”. Arch Esp Urol. 2009;62:423–9.
    1. Baxter FLOSEAL [Hemostatic matrix] instructions for use. 2005
    1. Renkens KL, Jr, Payner TD, Leipzig TJ, Feuer H, Morone MA, Koers JM, et al. multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976) 2001;26:1645–50.
    1. Eklof O, Lebowitz RL. Localized intra- and retroperitoneal gas collections following intraoperative use of surgical gelatine sponge. Pediatr Radiol. 1981;11:1–4.
    1. Sandrasegaran K, Lall C, Rajesh A, Maglinte DT. Distinguishing gelatin bioabsorbable sponge and postoperative abdominal abscess on CT. AJR Am J Roentgenol. 2005;184:475–80.
    1. Hayes, Sharon Caskey. "Discovery of Super Glue helped land Coover in National Inventors Hall of Fame", Kingsport Times-News. 2004 July 11.
    1. Ardis AE. US Patents No. 2467926 and 2467927. 1949
    1. Coover HN, Joyner FB, Shearer NH. Chemistry and performance of cyanoacrylate adhesives. Soc Plast Eng. 1959;15:413–7.
    1. Sierra DH, Saltz, Renato . Lancaster, PA: Technomic Publishing Company, Inc.; 1996. Surgical adhesives and sealants: current technology and applications.
    1. Testini M, Lissidini G, Poli E, Gurrado A, Lardo D, Piccinni G. A single-surgeon randomized trial comparing sutures, N-butyl-2-cyanoacrylate and human fibrin glue for mesh fixation during primary inguinal hernia repair. Can J Surg. 2010;53:155–60.
    1. Elmore JM, Smith EA, Kirsch AJ. Sutureless circumcision using 2-octyl cyanoacrylate (Dermabond): appraisal after 18-month experience. Urology. 2007;70:803–6.
    1. Aning JJ, Stott MA, Watkinson AF. Glue ablation of a late-presentation urinary fistula after partial nephrectomy. Br J Radiol. 2009;82:e246–8.
    1. Hong YM, Loughlin KR. The use of hemostatic agents and sealants in urology. J Urol. 2006;176:2367–74.
    1. van Dijk JH, Pes PL. Haemostasis in laparoscopic partial nephrectomy: current status. Minim Invasive Ther Allied Technol. 2007;16:31–44.
    1. Young ST, Paulson EK, McCann RL, Baker ME. Appearance of oxidized cellulose (Surgicel) on postoperative CT scans: similarity to postoperative abscess. AJR Am J Roentgenol. 1993;160:275–7.
    1. Sirlak M, Eryilmaz S, Yazicioglu L, Kiziltepe U, Eyileten Z, Durdu MS, et al. Comparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery. J Thorac Cardiovasc Surg. 2003;126:666–70.
    1. Bard Bard Announces FDA Clearance of Avitene Ultrafoam Collagen to Stop Bleeding During Surgery. Available from: [last cited on 2009]
    1. Msezane LP, Katz MH, Gofrit ON, Shalhav AL, Zorn KC. Hemostatic agents and instruments in laparoscopic renal surgery. J Endourol. 2008;22:403–8.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir